Focused Issue on Hepatic Resection with Molecular Markers

Posted On 2019-06-22 16:59:42


This focused issue on “Hepatic Resection with Molecular Markers” is edited by Dr. Yun Shin Chun, from The University of Texas MD Anderson Cancer Center, Houston, TX, USA; and Dr. Michael D’Angelica, from Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Dr. Yun Shin Chun is a surgical oncologist dedicated to the care of patients with malignancies of the liver and biliary tract. Her research focus is optimizing patient selection for hepatic resection using molecular markers, mutational profiles, and response to systemic therapy.

As a surgical oncologist, Dr. Michael D’Angelica cares for patients with benign and malignant (cancerous) diseases of the liver, bile duct, gallbladder, and pancreas. He also has an interest in benign pancreatic tumors, which do not necessarily merit immediate removal but should be carefully watched for any changes that warrant surgery.

Focused issue outline:

  1. Introduction to this focused issue
    Yun Shin Chun, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Michael D’Angelica, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  2. KRAS mutations in metastatic colorectal cancer: sites of disease and recurrence patterns
    Guillaume Passot, Department of Surgical Oncology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France; EMR 3738, Lyon 1 University, Lyon, France
  3. KRAS status and hepatic arterial infusion pump chemotherapy
    Sepideh Gholami, Memorial Sloan Kettering Cancer Center, USA
  4. Genomic alterations and their impact on systemic therapy
    Benny Johnson, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  5. Mutation location on RAS oncogene
    Josh Smith, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  6. Tailoring ablation strategies for colorectal liver metastases based upon RAS mutation status
    Bruno Odisio, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  7. Interactions of multiple gene mutations in colorectal liver metastases
    Yoshikuni Kawaguchi, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  8. National cancer database analysis of the impact of KRAS mutations in metastatic colorectal cancer
    Imran Hassan, Department of Surgery, University of Iowa Hospitals & Clinics, Iowa City, IA, USA
  9. SMAD4 mutations and colorectal liver metastases
    Takashi Mizuno, Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Jordan Cloyd, Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA
  10. Japanese experience with hepatic resection of KRAS-mutated colorectal liver metastases
    Junichi Shindoh, Hepatobiliary-pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan
  11. Limitations of genomic analysis
    Kristoffer Brudvik, Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway